Gabapentinoid Use Tied to Higher Risk for Hip Fractures
By Lori Solomon HealthDay Reporter
MONDAY, Nov. 18, 2024 -- Gabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in JAMA Network Open.
Miriam T.Y. Leung, from the Centre for Medicine Use and Safety at Monash University in Melbourne, Australia, and colleagues investigated the association between gabapentinoids and the risk for hip fractures in older adults. The analysis included 28,293 patients hospitalized for hip fracture between March 1, 2013, and June 30, 2018.
The researchers found that 10.4 percent were dispensed a gabapentinoid before hip fracture. There was an increased risk for hip fracture with gabapentinoid dispensing (odds ratio, 1.96). The odds of hip fractures remained elevated when adjusting for the exposure-time trend and concomitant use of other central nervous system medications (odds ratio, 1.30). In patients with a Hospital Frailty Risk Score of ≥5 and chronic kidney disease, the associations between gabapentinoid dispensing and hip fracture were higher (odds ratios, 1.75 and 2.41, respectively).
"These findings suggest that in addition to the known risk associated with kidney impairment, gabapentinoids should be used with caution among patients at risk of hip fractures, especially those who are frail," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Study IDs Predictors of Biomechanical Function in Patients With OA Undergoing Hip Replacement
WEDNESDAY, April 23, 2025 -- For patients undergoing total hip arthroplasty (THA), osteoarthritis (OA) severity is the best predictor of preoperative biomechanical function, and...
Birmingham Hip Resurfacing Safe, Effective Over 15 Years
MONDAY, April 21, 2025 -- Birmingham hip resurfacing (BHR) is effective and shows implant longevity in appropriately selected patients, according to a study published in the March...
American Academy of Orthopaedic Surgeons, March 10 to 14
The annual meeting of the American Academy of Orthopaedic Surgeons was held from March 10 to 14 in San Diego, drawing approximately 2,000 participants from around the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.